Danske Bank A S Sells 8,116 Shares of Tenet Healthcare Corporation $THC

Danske Bank A S cut its holdings in Tenet Healthcare Corporation (NYSE:THC) by 91.0% during the 4th quarter, Holdings Channel reports. The fund owned 800 shares of the company’s stock after selling 8,116 shares during the period. Danske Bank A S’s holdings in Tenet Healthcare were worth $159,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Triumph Capital Management purchased a new stake in Tenet Healthcare in the third quarter worth about $25,000. Activest Wealth Management purchased a new position in shares of Tenet Healthcare during the 4th quarter valued at about $26,000. William B. Walkup & Associates Inc. purchased a new stake in Tenet Healthcare in the 3rd quarter worth approximately $32,000. Canada Pension Plan Investment Board bought a new stake in Tenet Healthcare during the 2nd quarter worth approximately $35,000. Finally, Westside Investment Management Inc. boosted its position in shares of Tenet Healthcare by 100.0% in the third quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock worth $39,000 after purchasing an additional 96 shares during the period. 95.44% of the stock is owned by institutional investors.

Key Tenet Healthcare News

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Q1 beat and raised guidance: Tenet topped Q1 EPS estimates as admissions and ambulatory growth drove results, and the company raised its FY‑2026 EPS outlook — a clear catalyst supporting the rally even as management flagged payer‑mix pressure and rising costs that compressed margins. THC Beats Q1 Earnings Estimates on Strong Ambulatory Growth, Ups ’26 EPS View
• Positive Sentiment: Analyst support: RBC Capital reaffirmed its Buy stance on THC, which reinforces investor confidence that the company’s growth story remains intact. RBC Capital Sticks to Their Buy Rating for Tenet Healthcare (THC)
• Positive Sentiment: Investor narrative & momentum: Recent Zacks pieces highlight THC as a trending and high‑growth name (ambulatory expansion, above‑average financial growth), which can attract momentum flows and retail attention. Here is What to Know Beyond Why Tenet Healthcare Corporation (THC) is a Trending Stock Tenet (THC) is an Incredible Growth Stock: 3 Reasons Why
• Neutral Sentiment: Analyst / market commentary roundup: The Globe & Mail ran an analysts’‑insights piece covering Tenet alongside peers — useful for context but not an immediate catalyst. Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (THC) and Kymera Therapeutics (KYMR)
• Neutral Sentiment: Market commentary & valuation discussion: Several outlets (Yahoo, Zacks) are debating whether THC’s multi‑year rally leaves upside limited — important for positioning but mixed impact on price. Is It Too Late To Consider Tenet Healthcare (THC) After Its Strong Multi‑Year Rally?
• Neutral Sentiment: Compensation disclosure: Coverage summarizing CEO pay over the last five years is informational (governance/ESG interest) but not an immediate price mover. Tenet CEO pay in the last 5 years
• Negative Sentiment: Analyst downgrades & price target cuts: Robert W. Baird cut its price target to $210 and moved to a Neutral rating, trimming upside expectations; Stephens also cut its target to $260 — analyst mark‑downs can limit near‑term upside. Baird price target cut / coverage Tenet Healthcare (NYSE:THC) Price Target Cut to $260.00 by Analysts at Stephens
• Negative Sentiment: Quality/reputational risk: A Tenet executive commented publicly on a Leapfrog grade gap and broader issues “beyond 1 lawsuit,” which could raise investor concern about quality metrics, regulatory scrutiny, or reputation risk. Tenet executive on Leapfrog’s spring 2026 grade gap: ‘This goes way beyond 1 lawsuit’

Tenet Healthcare Stock Performance

Tenet Healthcare stock opened at $194.29 on Thursday. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96. Tenet Healthcare Corporation has a twelve month low of $146.60 and a twelve month high of $247.21. The company’s 50-day moving average price is $205.68 and its 200-day moving average price is $204.22. The company has a market cap of $16.74 billion, a PE ratio of 10.10, a price-to-earnings-growth ratio of 1.24 and a beta of 1.30.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, topping the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The company had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.39 billion. During the same quarter last year, the business posted $4.36 earnings per share. The firm’s revenue was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, equities research analysts forecast that Tenet Healthcare Corporation will post 17.56 EPS for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have recently commented on THC. Royal Bank Of Canada decreased their price objective on shares of Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating on the stock in a research report on Friday, May 1st. TD Cowen reissued a “buy” rating on shares of Tenet Healthcare in a report on Thursday, February 12th. Robert W. Baird dropped their price objective on Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating for the company in a research note on Tuesday. Wall Street Zen raised Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Sunday. Finally, Weiss Ratings restated a “buy (b-)” rating on shares of Tenet Healthcare in a research note on Friday, March 27th. Nineteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $244.16.

Insider Activity at Tenet Healthcare

In related news, insider R. Scott Ramsey sold 8,017 shares of the firm’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $232.70, for a total value of $1,865,555.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Paola M. Arbour sold 6,500 shares of the business’s stock in a transaction on Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the transaction, the executive vice president owned 29,291 shares in the company, valued at $6,983,853.13. This trade represents a 18.16% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 46,517 shares of company stock worth $10,943,111. Company insiders own 0.81% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.